A federal judge yesterday ordered embattled drugmaker Insys Therapeutics to pay a $2 million fine and $28 million in forfeiture for charges of mail fraud, the Boston Herald reported. The latest blow for the pharmaceutical company comes a month after it filed for bankruptcy, and two months after it was ordered to pay an additional $195 million payment as part of a civil resolution. The company, and former executives in a separate case, are charged with bribing doctors to prescribe excessive doses of their fentanyl spray, Subsys. Federal Judge Rya Zobel issued the fine yesterday in U.S. District Court in Boston for five charges of mail fraud as agreed to between prosecutors and Insys in a joint recommendation. The charges stem from five payments the company made to a physician’s assistant based in New Hampshire for fabricated speaking engagements about the spray.
